drugset / Trial / NCT01916291

Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38

NCT01916291

Phase 2 Completed 189 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Dinoprostone(propess) is commonly used for induction of labor in the pregnant women who has intact membrane after 38weeks of gestational age. The investigators study safety and efficacy of dinoprostone in the pregnant women with premature rupture of membrane or GA\<38weeks

Timeline

Start
2013-08-25
Primary completion
2018-08-14
Completion
2019-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified

Indications

No indication recorded.